HemaSphere (Aug 2023)
P522: OFF-THE-SHELF CD33 CAR-NK CELL THERAPY FOR RELAPSE/REFRACTORY AML: FIRST-IN-HUMAN, PHASE I TRIAL
- Ruihao Huang,
- Qin Wen,
- Xiaoqi Wang,
- Hongju Yan,
- Yingying MA,
- Maihong Wang,
- Xiao Han,
- Jia Liu,
- LI Gao,
- Lei Gao,
- Cheng Zhang,
- XI Zhang
Affiliations
- Ruihao Huang
- 1 Xinqiao Hospital, Army Medical University, Medical center of hematology, Chongqing, China
- Qin Wen
- 1 Xinqiao Hospital, Army Medical University, Medical center of hematology, Chongqing, China
- Xiaoqi Wang
- 1 Xinqiao Hospital, Army Medical University, Medical center of hematology, Chongqing, China
- Hongju Yan
- 1 Xinqiao Hospital, Army Medical University, Medical center of hematology, Chongqing, China
- Yingying MA
- 1 Xinqiao Hospital, Army Medical University, Medical center of hematology, Chongqing, China
- Maihong Wang
- 1 Xinqiao Hospital, Army Medical University, Medical center of hematology, Chongqing, China
- Xiao Han
- 1 Xinqiao Hospital, Army Medical University, Medical center of hematology, Chongqing, China
- Jia Liu
- 1 Xinqiao Hospital, Army Medical University, Medical center of hematology, Chongqing, China
- LI Gao
- 1 Xinqiao Hospital, Army Medical University, Medical center of hematology, Chongqing, China
- Lei Gao
- 1 Xinqiao Hospital, Army Medical University, Medical center of hematology, Chongqing, China
- Cheng Zhang
- 1 Xinqiao Hospital, Army Medical University, Medical center of hematology, Chongqing, China
- XI Zhang
- 1 Xinqiao Hospital, Army Medical University, Medical center of hematology, Chongqing, China
- DOI
- https://doi.org/10.1097/01.HS9.0000968996.69938.df
- Journal volume & issue
-
Vol. 7
p. e69938df
Abstract
No abstracts available.